XOPENEX Rx

Select the drug indication to add to your list

XOPENEX

Asthma/COPD
Only 4 drugs may be compared at once

Generic Name and Formulations:

Levalbuterol (as HCl) (single-isomer albuterol) 0.31mg/3mL, 0.63mg/3mL, 1.25mg/3mL; per vial; inhalation soln; preservative-free.

Company:

Sunovion

Select therapeutic use:

Indications for XOPENEX:

Bronchospasm.

Adult:

Initially 0.63mg by nebulization 3 times daily at 6–8 hr intervals; may increase to 1.25mg 3 times daily.

Children:

<6 years: not recommended. 6–11 years: 0.31mg by nebulization 3 times daily; max 0.63mg 3 times daily.

Warnings/Precautions:

Do not exceed recommended dose. Monitor for increased need; if inadequate control, reevaluate and consider adding an antiinflammatory (eg, corticosteroids). Sensitivity to sympathomimetics. Discontinue if paradoxical bronchospasm or cardiovascular effects occur. Cardiovascular disorders (esp. coronary insufficiency, arrhythmias, hypertension). Seizure disorders. Diabetes. Hyperthyroidism. Renal impairment; monitor (esp. in elderly). Elderly. Labor & delivery. Pregnancy. Nursing mothers.

See Also:

XOPENEX HFA

XOPENEX CONCENTRATE

Pharmacological Class:

Beta-2 agonist.

Interactions:

Avoid within 2 weeks of MAOIs, tricyclic antidepressants. Avoid other short-acting sympathomimetic aerosol bronchodilators, epinephrine. Antagonized by β-blockers. Caution with other drugs that may lower serum potassium (eg, diuretics). Monitor digoxin.

Adverse Reactions:

Accidental injury, bronchitis, dizziness, pain, pharyngitis, rhinitis, vomiting; paradoxical bronchospasm, hypersensitivity reactions, cardiovascular effects, hypokalemia.

Generic Availability:

Vials (YES); HFA (NO)

How Supplied:

Inhaler w. actuator (80inh)—8.4g, (200 inh)—15g; Soln 0.31mg/3mL, 0.63mg/3mL, 1.25mg/3mL—24 vials; Concentrate 1.25mg/0.5mL—30 vials